PositiveID Corp., a developer of medical devices and biological detection systems focusing primarily on diabetes management, rapid medical testing, and airborne bio-threat detection, today issued a press release review its major accomplishments in the past year. As 2012 approaches, PositiveID is excited to look into the future for more fantastic developments as well as revenues from the initial rollout of iglucose™.
One of the major accomplishments for the company includes receiving FDA clearance for iglucose™ and successfully completing Federal Communications Commission (FCC) requirements to be retailed in the U.S. PositiveID has also completed a prototype of Easy Check(TM), a non-invasive, blood free, painless, breath glucose detection device; acquired MicroFluidic Systems, a leader in biothreat detection technologies and molecular diagnostic systems; completed Phase II development of GlucoChip(TM), a continuous glucose-sensing microchip; and positioned MicroFluidic Systems for key government programs, which includes the Department of Homeland Security’s (“DHS”) $3 billion BioWatch program.
In regards to PositiveID’s subsidiary MicroFluidic Systems, the BioWatch program is the nation’s very first early warning network of sensors used to detect biological attacks. The ability to rapidly identify a biological agent will potentially save the lives of patients. Generation 3 of BioWatch represents the very first advancement in BioWatch technologies, far beyond manual collection and analysis by creating a “lab in the box” detection system. PositiveID believes there are only two technologies, one of which it owns in its M-BAND system, that can measure up to the requirements of Generation 3 BioWatch.
PositiveID Corporation develops medical devices and biological detection systems focusing primarily on diabetes management, rapid medical testing, and airborne bio-threat detection. The company also strives in the development of the GlucoChip, a glucose-sensing microchip; iglucose, a stand-alone self-contained unit that automatically queries a diabetic user’s data-capable glucometer for blood glucose data and sends that data through encrypted text messaging to the iglucose online database; Easy Check, a non-invasive breath glucose detection system; and the rapid flu detection system. PositiveID Corporation was founded in 2001 and is based in Delray Beach, Florida.
For more information on the Company, visit www.positiveidcorp.com
About QualityStocks:
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://Gotstocks.QualityStocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment